Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains

Neuroprotection by a caspase inhibitor in acute bacterial meningitis.

J S Braun1, R Novak, K H Herzog

  • 1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Nature Medicine
|March 23, 1999

Related Experiment Videos

View abstract on PubMed

Summary
This summary is machine-generated.

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Medical Microbiology
  • Medical Infection Agents (incl. Prions)
  • Neuroprotection By A Caspase Inhibitor In Acute Bacterial Meningitis.

    • Caspase inhibitors, like z-VAD-fmk, can prevent brain damage and neuronal cell death in bacterial meningitis survivors. This offers a potential new therapy to reduce neurological deficits after infection.

    Area of Science:

    • Neuroscience
    • Infectious Diseases
    • Pharmacology

    Background:

    • Bacterial meningitis survivors often face long-term neurological deficits.
    • Antibiotics effectively kill bacteria but do not prevent this brain damage.

    Purpose of the Study:

    • To investigate the role of apoptosis in meningitis-induced neuronal death.
    • To evaluate the therapeutic potential of caspase inhibitors in preventing brain damage during pneumococcal meningitis.

    Main Methods:

    • Experimental pneumococcal meningitis model.
    • Administration of a broad-spectrum caspase inhibitor (z-VAD-fmk).
    • Assessment of hippocampal neuronal cell death and inflammatory markers in cerebrospinal fluid.

    Main Results:

    • z-VAD-fmk significantly reduced hippocampal neuronal cell death.
    • The caspase inhibitor also decreased white blood cell influx into the cerebrospinal fluid.
    • Inflamed cerebrospinal fluid induced apoptosis in human neurons in vitro, which was blocked by z-VAD-fmk.

    Conclusions:

    • Apoptosis, triggered by inflammation, is a key mechanism of neuronal loss in pneumococcal meningitis.
    • Caspase inhibitors represent a promising therapeutic strategy to mitigate brain damage and neurological impairments in meningitis survivors.

    Related Experiment Videos